Home Biosimilar Antibodies Immunology & Inflammation CD markers antibody Ibritumomab (Anti-CD20) For research use only.
Not for use in humans.

Ibritumomab (Anti-CD20)

Synonyms:

Ibritumomab (anti-CD20) is a monoclonal antibody targeting anti-CD20 used to treat B-cell non-Hodgkin's lymphoma. MW: 144.52 KD.

Ibritumomab (Anti-CD20)

Purity & Quality Control

≥99

Choose Selective CD markers Inhibitors

Biological Activity

Description Ibritumomab (anti-CD20) is a monoclonal antibody targeting anti-CD20 used to treat B-cell non-Hodgkin's lymphoma. MW: 144.52 KD.

Product Details

CAS No. 206181-63-7
Molecular Weight 144.52
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Ibritumomab (Anti-CD20) | Ibritumomab (Anti-CD20) supplier | purchase Ibritumomab (Anti-CD20) | Ibritumomab (Anti-CD20) cost | Ibritumomab (Anti-CD20) manufacturer | order Ibritumomab (Anti-CD20) | Ibritumomab (Anti-CD20) distributor